Veracyte (VCYT) Stock: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$44.19
-1.85 (-4.02%)
▼
5d:
-8.96%
30d:
+1.75%
90d:
-22.58%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VCYT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VCYT shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$53.82
Based on 3.0% avg growth
INTRINSIC VALUE TODAY
$33.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $44.19, which is considered extended relative to its 30-day fair value range of $40.91 to $45.23. The stock's valuation (Forward PE: 22.6) is in line with its historical norms (23.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.6% over the next few years. This pessimistic expectation contrasts with the company's recent 288.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VCYT is in a downtrend. Immediate support is located at $39.40, while resistance sits at $49.00. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: VCYT scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $58.42 (+32.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VCYT is in a downtrend. Immediate support is located at $39.40, while resistance sits at $49.00. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: VCYT scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $58.42 (+32.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.91 -
$45.23
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Protect Your Profits
Holding VCYT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 32.2% below Wall St target ($58.42)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$40.91 -
$45.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$39.40
Resistance Level
$49.00
Current Trend
Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.65
Wall Street Target
$58.42
(+32.2%)
Revenue Growth (YoY)
15.5%
Earnings Growth (YoY)
288.9%
Profit Margin
20.4%
Valuation Discount vs History
-1.6% cheaper
PE vs Historical
22.7 vs 23.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.6%
(market-implied from PE analysis)
1-Year Target
$43.48
(-2%)
2-Year Target
$42.79
(-3%)
3-Year Target
$42.10
(-5%)
3-Yr Target (if PE normalizes)
(PE: 23→24)
$44.24
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.6, Growth: 2.0%)
$46.85
(+6%)
Base:
(SPY PE: 20.4, Growth: 2.0%)
$42.19
(-5%)
Bear:
(PE: 17.3, Growth: 2.0%)
$35.86
(-19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 32.89 | Current EPS (TTM): $1.40
Bull Case
$70.58
(+60%)
Analyst growth 39.4%, PE expands to 36.2
Base Case
$64.16
(+45%)
Market implied 39.4%, PE stable at 32.9
Bear Case
$31.31
(-29%)
Severe decline -20.0%, PE contracts to 28.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.6 to 23.8
Stabilization Target:
$46.43
(+5.1%)
PE Expansion Potential:
+5.1%
Share & Embed Analysis
Last updated: October 01, 2026 6:21 PM ET
Data refreshes hourly during market hours. Next update: 7:21 PM
Data refreshes hourly during market hours. Next update: 7:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 65 BUY |
Advanced VCYT Option Strategies
Professional options setups generated by AI based on today's VCYT price and gamma walls.
